TrialTargeted oncology2025

Fruquintinib Plus Sintilimab in Patients with Treatment-Naive and Previously Treated Advanced Renal Cell Carcinoma: Results from a Phase Ib/II Clinical Trial.

Hua Xu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.